Summary
The Food and Drug Administration (FDA) will meet this summer to consider loosening rules on several unapproved peptide injections. These peptides are promoted as quick solutions for muscle growth and healing, but they lack strong scientific evidence and FDA safety approval.
Key Facts
- The FDA plans to discuss allowing pharmacies to produce seven peptides currently not approved.
- Health Secretary Robert F. Kennedy Jr. supports easing restrictions on peptides and has spoken about using them for his own injuries.
- Peptides are popular among wellness influencers and supporters of the Make America Healthy Again movement.
- Most peptides have little research backing their safety or effectiveness.
- In the past, the FDA under President Biden banned nearly 20 peptides from being made by compounding pharmacies due to safety concerns.
- The upcoming FDA panel meeting will review whether to add the peptides to a safe production list.
- Some experts warn that loosening rules without full testing could threaten drug safety standards.
- The FDA panel currently has vacancies that Secretary Kennedy may fill before the meeting.
